Acute Management of Anoxic Brain Injury
For patients with anoxic brain injury, actively prevent fever by targeting temperature ≤37.5°C for at least 36 hours, maintain normoxia (PaO₂ 80-120 mmHg), target normocapnia, keep MAP ≥65 mmHg, and treat clinical seizures with levetiracetam and/or sodium valproate—do not use prophylactic antiepileptics. 1, 2
Temperature Management
The most critical intervention is temperature control:
- Target temperature ≤37.5°C for all comatose post-cardiac arrest patients 1
- Minimum duration: 36 hours of total temperature control 2
- Whether targeting deeper hypothermia (32-34°C) provides additional benefit remains uncertain, but fever prevention is definitively beneficial 1
- Use device-based temperature control when available to maintain precise targets
Respiratory Management
Oxygenation targets:
- Maintain normoxia with PaO₂ 80-120 mmHg 3
- Avoid both hypoxemia (clearly harmful) and hyperoxia (associated with worse neurological outcomes and mortality) 3
- Do not provide supplemental oxygen beyond what is needed to achieve normoxia
Ventilation targets:
- Target eucapnia (normocapnia) 2, 4
- Adjust ventilator settings immediately post-intubation to achieve this
- Use lung-protective strategies with tidal volumes in protective ranges and limited plateau pressures 5
Hemodynamic Management
- Target MAP ≥65 mmHg 4
- No specific vasopressor is recommended over others; insufficient evidence exists to prefer epinephrine, norepinephrine, or dopamine 2
- Consider temporary mechanical circulatory support only in highly selected patients with refractory cardiogenic shock 2
- Maintain euvolemia; use normal saline as first-line maintenance fluid 3
Seizure Management
Critical distinction: Treat clinical seizures aggressively, but do NOT use prophylactic antiepileptics 1
For clinical seizures or status epilepticus:
- First-line: Levetiracetam and/or sodium valproate (alone or in combination) 1
- Second-line: Increase propofol or benzodiazepine doses to suppress myoclonus and electrographic seizures 1
- Third-line: Consider thiopental or phenobarbital in selected patients 1
- Avoid phenytoin/fosphenytoin due to negative inotropic and vasodilating effects in post-arrest patients 1
EEG monitoring:
- Perform EEG promptly for any patient with myoclonus to diagnose seizures 2
- Continuous EEG monitoring reveals that electrographic and clinical seizures overlap substantially 1
- EEG background pattern is prognostically important: continuous, normal voltage, and reactive backgrounds are favorable; burst-suppression or suppressed non-reactive backgrounds indicate worse prognosis 1
Important caveat: Prophylactic antiepileptics show no benefit and are not recommended 1. Treatment with high-dose sedatives and antiepileptics may delay awakening and prolong mechanical ventilation 1.
Prognostic Assessment
Since seizures and status epilepticus reflect the severity of hypoxic-ischemic injury, integrate prognostic assessment into treatment decisions:
- Use multimodal assessment: somatosensory evoked potentials, serum NSE, and MRI (preferred over CT) 1
- These modalities are less affected by sedative drugs than EEG alone
- Early seizure onset (<24 hours) before recovery of continuous EEG background indicates worse prognosis 1
- Treat the patient holistically rather than focusing purely on EEG suppression 1
Diagnostic Workup
- 12-lead ECG is mandatory 2
- Consider CT, echocardiography, or point-of-care cardiac ultrasound to identify underlying causes 2
- Perform comprehensive neurological examination when feasible before intubation 6
Critical Pitfalls to Avoid
- Do not use prophylactic antiepileptics—no evidence of benefit 1
- Avoid hyperoxia—target normoxia, not supranormal oxygen levels 3
- Do not allow fever—even mild hyperthermia worsens outcomes 1
- Avoid hypotension—maintain adequate MAP 4
- Do not over-sedate to suppress EEG alone—this delays awakening without proven benefit and may obscure prognostic assessment 1
Realistic Outcome Expectations
Recent multicenter data shows that patients remaining comatose or in vegetative state at 2 weeks have poor long-term outcomes: only 1.8% achieved functional independence (CPC 1-2) at 12 months, while 39.6% died and most survivors remained severely disabled 7. This information is crucial for informed goals-of-care discussions with families, particularly when considering prolonged aggressive interventions beyond the acute phase.